BamSEC and AlphaSense Join Forces
Learn More

Traws Pharma Inc.

NASDAQ: TRAW    
Share price (12/24/24): $11.61    
Market cap (12/24/24): $35.1 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.22
from 10-K 3 pages Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Act of 1934
12/34/56
EX-4.1
from 8-K 15 pages Placement Agent Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 15 pages Placement Agent Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 15 pages Placement Agent Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 15 pages Placement Agent Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 15 pages Pre-Funded Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 16 pages Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.19
from S-1/A 21 pages Placement Agent Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.18
from S-1/A 20 pages Pre-Funded Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.17
from S-1/A 21 pages Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.19
from S-1/A 21 pages Underwriter Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.18
from S-1/A 20 pages Pre-Funded Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.17
from S-1/A 21 pages Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.1
from 10-Q 3 pages Holder of Series a Preferred Stock Warrants and/or Series B Preferred Stock Warrants (The “Holder”) [·] Re: Amendment to Warrants Dear Holder
12/34/56
EX-4.1
from 8-K 19 pages Placement Agent Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.1
from 10-Q 2 pages Onconova Therapeutics, Inc. First Amendment to Underwriter Series a Convertible Preferred Stock Purchase Warrant
12/34/56
EX-4.2
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 9 pages Series B Convertible Preferred Stock Purchase Warrant Onconova Therapeutics, Inc
12/34/56